TD Private Client Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

TD Private Client Wealth’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.77K	Hold	605	–	–	﹤0.01%	1143
2026 Q1	$8.38K	Hold	605	–	–	﹤0.01%	1126
2025 Q4	$8.49K	Buy	605 +275	+83%	+$3.86K	﹤0.01%	1106
2025 Q3	$4.61K	Hold	330	–	–	﹤0.01%	1141
2025 Q2	$4.96K	Hold	330	–	–	﹤0.01%	1112
2025 Q1	$4.35K	Hold	330	–	–	﹤0.01%	1098
2024 Q4	$5.21K	Hold	330	–	–	﹤0.01%	1104
2024 Q3	$5.24K	Buy	+330	New	+$5.31K	﹤0.01%	1110
2024 Q1	–	Sell	-570	Closed	-$7.93K	–	1255
2023 Q4	$7.93K	Sell	570 -1,000	-64%	-$13.4K	﹤0.01%	1074
2023 Q3	$21K	Buy	1,570 +1,500	+2,143%	+$20.3K	﹤0.01%	924
2023 Q2	$884	Sell	70 -12,275	-99%	-$143K	﹤0.01%	1219
2023 Q1	$141K	Buy	+12,345	New	+$133K	0.01%	602

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TD Private Client Wealth's RDY Position: Q2 2026 in Review

TD Private Client Wealth held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 605 shares worth $8.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

TD Private Client Wealth first reported a position in RDY in Q1 2023 and has held it in 12 quarters since. The position peaked at $141K in Q1 2023. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

TD Private Client Wealth held 605 shares of Dr. Reddy's Laboratories worth $8.77K as of Q2 2026.
TD Private Client Wealth left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1143 holding.
TD Private Client Wealth first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 12 quarters since.
TD Private Client Wealth's Dr. Reddy's Laboratories position peaked at $141K in Q1 2023.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.